Budget Impact of Metastatic Castrate-Resistant Prostate Cancer (CRPC) to German Payers von Jensen, I.S, Wu, C, Cyr, P.L, White, R.E

Volltext

Use of Oritavancin for the Treatment of Skin and soft Tissue Infections: A Uk Hospital Budget Impact Analysis von Wu, C, Jensen, I.S, Cyr, P.L, Fan, W, Mitchell, M, Sulham, K, Nathwani, D

Volltext

PSU15 Impact of Complications in Solid Organ Transplants on Hospital Charges and Length of Stay von Jensen, I.S, Helm, T, Cyr, P.L

Volltext

PIN9 A German Hospital Budget Impact Model Comparing Antibiotic Therapies in Complicated Skin and Skin Structure Infections and Bacteremia von Jensen, I.S, Ogborne, R, Cyr, P.L

Volltext

A Us Hospital Economic Impact Model for Oritavancin In Absssi Patients With Risk of Mrsa Infections von Wu, C, Fortier, K.J, LaPensee, K, Fan, W, Mitchell, M, Cyr, P.L, Jensen, I.S

Volltext

EE539 Estimating the Lifetime Burden of Illness in Patients with Bronchiolitis Obliterans Syndrome (BOS) von Jensen, I.S., Srivastava, K., Minshall, M.E., Kemp, R.

Volltext

EE285 Evaluating the Face Validity of Health State Utility Values (HSUVS) for Metachromatic Leukodystrophy (MLD) von Bean, K., Miller, B., Jensen, I.S., Fields, C., Pang, F.

Volltext

Incorporating Stakeholder Input into Budget Impact Models to Compare Stem Cell Mobilization Strategies von Jensen, I.S, Halbert, R.J, Grosvenor, A, Schwartz, E.L, Rossi, D.G, Naoshy, S, Iqbal, S.U, Xiao, Z, McSweeney, P.A

Volltext

PGI9 Impact of Dysphagia on U.S. Hospital Charges in Patients with Comorbid Conditions von Helm, T, Jensen, I.S, Cyr, P.L

Volltext

PGI7 Impact of Complications from Dysphagia on Hospital Charges in the United States von Jensen, I.S, Helm, T, Cyr, P.L

Volltext

EE579 Cost Consequences of Using Clevidipine in Neurological Emergencies from the Perspective of a US Hospital von Gutierrez, M., Wild, S., Compton, A., Paine, E., Jensen, I.S., Shah, A.

Volltext

EE125 Cost Consequences of Using Clevidipine in Acute Hypertension from the Perspective of a US Hospital von Gutierrez, M., Wild, S., Compton, A., Paine, E., Jensen, I.S., Shah, A.

Volltext

EE303 Cost-Utility Analysis of Roflumilast Cream for Plaque Psoriasis, Including Intertriginous, From the Canadian Societal Perspective von Garrison, K., Zhang, W., Jensen, I.S., Shah, A., Brown, S., Stephenson, B., Yim, C.

Volltext

EE393 The Cost-Effectiveness of Atidarsagene Autotemcel (Arsa-Cel) for the Treatment of Metachromatic Leukodystrophy (MLD) in the US von Pang, F., Dean, R., Jensen, I.S., Bean, K., Fields, C., Miller, B.

Volltext

EE547 The Societal Costs of Metachromatic Leukodystrophy (MLD) in the United States von Bean, K., Miller, B., Jensen, I.S., Howle, K., Wilds, A., Walz, M., Fields, C., Pang, F.

Volltext

EE734 Cost Consequences of Using Clevidipine in Cardiac Surgery from the Perspective of a US Hospital von Gutierrez, M., Wild, S., Compton, A., Paine, E., Jensen, I.S., Shah, A.

Volltext

EE408 Direct Cost Analysis Associated with the Management of Patients with Metachromatic Leukodystrophy (MLD) across Nine European Countries von Bean, K., Olaye, A., Miller, B., Jensen, I.S., Dean, R., Pang, F.

Volltext

EE658 Cost-Consequence of Cladribine Tablets for the Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis (RRMS) in the UK von Miller, B., Russel-Szymczyk, M., Jensen, I.S., Shah, A., Alexopoulos, S.T., Herbert, A., McLean, T., Tundia, N.

Volltext

PMS57 Understanding the Impact of XLMTM on Parents and Caregivers in the US: An Analysis of Survey Results von Miller, B., Yao, W., Dean, R., Jensen, I.S., Cyr, P.L., Slocomb, T.

Volltext

PCN38 ECONOMIC ANALYSIS OF COLORECTAL CANCER SCREENING FROM MULTIPLE STAKEHOLDER PERSPECTIVES: KEY COMPONENTS TO IMPROVE PRACTICAL APPLICATIONS IN THE US von Hathway, J., Jensen, I.S., Cyr, P.L., Koshy, T.I., Parks, P., Weinstein, M.C.

Volltext